2Hanefeld M, Bounter K P, Dikision S, et al. Rapid and short - acting mealtime insulin secretion with nateglinide controls both prandial and mean glycemia. Diabetes Care, 2000, 23(2) :202.
3Hu S, Wang S, Fanelli B, et al. Pancreatic beta-cell K(ATP) channel activity and membrane - binding studies with nateglinide: a comparison with sulfonylureas and repaglinide. J Pharmacol Exp Ther, 2000, 293 (2) :444.
4Uehino H, Niwa M, Shimizu T, et al. Impairment of early insulin response after glucose load, rather than insulin resistance, is responsible for postprandial hyperglycemia seen in obese type 2 diabetes: assessment using nateglinide, a new insulin secretagogueo Endocr J, 2000, 47 (5) : 639.
5Monnier I,Lapindki H,Colette C.Contributions of fasting and poslprandisl plasma glucose inetements to the overall diurnal hypergly cemia of type 2 diabetic patients[J].Diabetes Care,2003,26:881 -885
6DeFronzo RA,Bonadonna RC,Ferrannini E.Pathogenesis of NIDDM:a precarious balance between insulin action and insulin secretion//KGMM Alberti,DeFronzo RA,Keen H,Zimmet P,Eds.International Textbook of Diabetes Mellitus[M].New York:John Wiley & Sons Ltd,1992:569-633
7Crepaldi G,Del-Prato Del.What therapy do our NIDDM patients need? Insulin releasers[J].Diabetes Res Clin pract,1995,28(suppl):S159-S165
8Warram JH,Sigal RJ,Martin BC,et al.Natural history of impaired glucose tolerance:follow-up at Joslin Clinic[J].Ciabet Med,1998,13(Suppl 6):40-45
9Haller H.Postprandial glucose and vascular disease[J].Diabet Med,1997,14 (Suppl):50-56
10Haller H.The clinical importance of post-prandial glucose[J].Diabetes Res Clin Pract,1998,40(Suppl):43-49
